UBS AM’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-31,431
| Closed | -$128K | – | 2711 |
|
|
2023
Q2 | $128K | Hold |
31,431
| – | – | ﹤0.01% | 2618 |
|
|
2023
Q1 | $128K | Hold |
31,431
| – | – | ﹤0.01% | 2618 |
|
|
2022
Q4 | $158K | Buy |
31,431
+664
| +2% | +$3.33K | ﹤0.01% | 2470 |
|
|
2022
Q3 | $402K | Sell |
30,767
-3,896
| -11% | -$51K | ﹤0.01% | 2422 |
|
|
2022
Q2 | $444K | Buy |
34,663
+16,034
| +86% | +$206K | ﹤0.01% | 2353 |
|
|
2022
Q1 | $284K | Hold |
18,629
| – | – | ﹤0.01% | 2612 |
|
|
2021
Q4 | $330K | Sell |
18,629
-6,316
| -25% | -$112K | ﹤0.01% | 2660 |
|
|
2021
Q3 | $524K | Buy |
24,945
+14,754
| +145% | +$310K | ﹤0.01% | 2482 |
|
|
2021
Q2 | $201K | Buy |
+10,191
| New | +$201K | ﹤0.01% | 2709 |
|